| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,710 |
6,247 |
$278K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,160 |
1,990 |
$138K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,576 |
1,489 |
$135K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
888 |
840 |
$39K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
904 |
840 |
$29K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
364 |
337 |
$18K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
103 |
98 |
$8K |
| 99000 |
|
805 |
770 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25 |
24 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
24 |
24 |
$363.19 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$200.68 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
12 |
12 |
$44.00 |
| 94760 |
|
14 |
14 |
$21.04 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
14 |
13 |
$11.55 |